Physician profile
Gary L Wagoner
NPI 1225034853
$1,772.57
in general payments reported to CMS, 2019-2025
22 companies · $20.37 in 2025
The $20.37 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $439 · 2021: $979 · 2025: $20.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $452.54 | 2019-2021 | |
| Abbvie INC. | $147.02 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $146.91 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $129.79 | 2019-2021 | |
| Novo Nordisk INC | $121.33 | 2019-2021 | |
| Eisai INC. | $119.77 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.26 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $84.77 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $71.09 | 2020-2021 | |
| Pfizer INC. | $66.27 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $49.75 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $47.34 | 2021 | |
| Amgen INC. | $43.74 | 2019-2021 | |
| Horizon Therapeutics Plc | $31.72 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.52 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $21.24 | 2019 | |
| Boston Scientific Corporation | $20.37 | 2025 | Watchman Flx |
| Amarin Pharma, INC. | $16.47 | 2021 | |
| Esperion Therapeutics, INC. | $15.42 | 2021 | |
| Allergan, INC. | $14.86 | 2020 | |
| Glaxosmithkline, LLC. | $14.42 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Wagoner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.